基于临床因素的风险分层,用于精密治疗子宫部局部晚期状细胞癌的临床因素

Feng-Yuan Liu1,2,3, Wei-Chun Chen3,4,5, Yu-Bin Pan6

  • 1Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital at Linkou and Chang Gung University College of Medicine, Taoyuan, Taiwan.

Cancer medicine
|January 9, 2024
PubMed
概括

这项研究确定了年龄,原发性瘤代谢瘤体积 (MTV) 和PET/CT上阳性盆腔或副大动脉淋巴结 (PALN) 作为局部晚期宫癌患者生存的关键预测因素. 这些因素可以指导治疗决策,以改善患者的治疗结果.